BETA: Please send your feedback!
Amgen
AMGN:NAS
Biotechnology
—
MEGA cap
(—)
—
since start of 2021
—
- 1
- 3
- 1
- 2
- —
- 3
- 4
- 2
- 5
- —
- —
- 5
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
About
Biotechnology
Founded 1980
Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. Its products include aranesp, blincyto, corlanor, enbrel, epogen, imlygic, kyprolis, neulasta, neupogen, nplate, parsab, prolia, repatha, sensipar, vectibix, and xgeva. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
website
Headquarters
Executives
Name | Title | Gender |
Joseph Rubinfeld, PhD | Founder | Male |
Pitch Johnson, Jr., MBA | Founder | Male |
Jonathan P. Graham | Secretary, Senior Vice President & General Counsel | Male |
Lori A. Johnston | Senior Vice President-Human Resources | Female |
Bill Bowes, Jr., MBA | Founder | Male |
George B. Rathmann, PhD | Founder | Male |
Leroy E. Hood, MD, PhD | Founder | Male |
Robert A. Bradway, MBA | Chairman & Chief Executive Officer | Male |
Arvind K. Sood | Investor Relations Contact | Male |
David W. Meline, MBA | Chief Financial Officer & Executive Vice President | Male |
Steven K. Galson, MD | Senior VP-Global Regulatory Affairs & Safety | Male |
Sean E. Harper, PhD | Executive Vice President-Research & Development | Male |
Victoria H. Blatter | Senior Vice President-US Government Affairs | Female |
Paul R. Eisenberg, MD | Chief Medical Officer & Senior VP-Global Medical | Male |
Esteban Santos | Executive Vice President-Operations | Male |
Mindful Investing Summary
Amgen - Competitors and Related Companies
How Amgen stacks up to its peers in the Biotechnology industry or with competing business segments.
Amgen
AMGN:NAS
Biotechnology
—
MEGA cap
(—)
—
since start of 2021
—
- 5
- 5
- 5
- —
- 5
- 5
- 1
- 2
- 5
- —
- —
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Abbott Laboratories
ABT:NYS
Medical Specialties
—
MEGA cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Celgene
CELG:NAS
Biotechnology
—
MEGA cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 2
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Gilead Sciences
GILD:NAS
Biotechnology
—
MEGA cap
(—)
—
since start of 2021
—
- 1
- 3
- 1
- 2
- —
- 3
- 4
- 2
- 5
- —
- —
- 5
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
GlaxoSmithKline
GSK-GB:LON
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Alexion Pharmaceuticals
ALXN:NAS
Biotechnology
—
LARGE cap
(—)
—
since start of 2021
—
- 1
- 3
- 1
- 2
- —
- 3
- 4
- 2
- 5
- —
- —
- 5
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership